hi Frank,my suggestion is let your wife buy expensive shoes...

hi Frank,
my suggestion is let your wife buy expensive shoes works for me.
I have a large amount of PAR that is deeply in the red. For me I tend to not look at the shareprice or my net return in my commsec account as a determination of success. The fundamentals and continued success of trials is much more important to me.
Also having done some very conservative pricing models in the past you realise even with 100% dilution at the current stage the potential shareprice based on conservative numbers are mind blowing (refer to some of the models in this forum).

the problem however is PAR is really a binary bet. If it gets up you win if not you don’t. So the secret needs to be on allocate what u are willing to lose. At the end of the day you are betting on an FDA registration.

Lets hope the 12 month data looks good on 008 as the increased chance of DMOAD only enhances our label….. in the back of my mind I keep thinking if the FDA have approved this in animals for OA they can’t block it in humans if it is safe and works. They have the same labelling restrictions in the vet world where IPPS is marketed as DMOAD.

Time will tell.

The Pool

ps jump in anytime famerBob